PPT-Training for Providers on the Use of Oral Pre-exposure Prophylaxis for the Prevention

Facilitator Background Materials Review these slides prior to using these materials Introduction to Training Materials These training materials May need to be modified for use if national guidelines do not align with WHO guidance as of March 2022. for HIV PreventionMay 2014Fast Facts Pre-exposure prophylaxis, or PrEP, is a way to help prevent HIV by taking a pill every day. People who are at substantial risk for HIV should talk to their doctor Infectious Disease Fellowship Program Director. Associate Professor of Clinical Medicine. University of . Arizona. Cesar Egurrola, Clinical Coordinator. Petersen HIV Clinics. University of Arizona. Special thanks:. Kevin L. Ard, MD, MPH. October 20, 2016. Learning objectives. Summarize the indications for and management of pre- and post-exposure prophylaxis. Understand clinical uncertainties in pre-exposure prophylaxis management. Presenter:. INTRODUCTION. This project was supported through Federal funds from the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Grant # UM01 AI068614: “Leadership Group for a Global HIV Vaccine Clinical Trials (Office of HIV/AIDS Network . April 4, 2019 3:00 pm ET HHS Office of Population Affairs PrEP for HIV Prevention in Title X Funded Family Planning Sites National Kick-Off Webinar Note: This call will be recorded Objectives Discuss the role of Title X family planning clinics in assuring access to PrEP services in their communities Integrating Pre-Exposure Prophylaxis ( PrEP ) into the Primary Care Setting Christine Kerr, MD Medical Director of HIV, Hepatitis, and Specialty Care Hudson River HealthCare February 12, 2016 Why Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research and Education and Ronald Reagan Medical Center Zindoga. Mukandavire. 1. , . Graham F. Medley. 1. , Fern Terris-Prestholt. 1. ,. . Daniel J. Klein. 2. , Anna Bershteyn. 2. , Katharine Kripke. 3. , Joseph Murungu. 4. , . Definate. Nhamo. 4. ,. . NURS RESEARCH POROJECT PROPOSA. NURS 503. Name:…………. Ana G Mendez University. Facilitator: Nancy Woelki . DNP, APRN, MSN, RN. Date:………... The purpose of this research was to evaluate the advantage and disadvantage using of PrEP for HIV-negative adults with high risk for HIV.. Michael Nevill. Director of Nursing, BPAS. NICE Guideline Committee Member. The views expressed in this presentation are those of the authors and not necessarily those of NICE. Guideline is available from:. Geneva 2019. Dr Venkatraman Chandra-Mouli. DEFINITIONS . Human immunodeficiency virus (HIV): . A virus that targets the immune system & weakens the body’s defense system against infections. . Antiretroviral medicines (ARVs): . , PEP, PREP . Compiled by Jason Vermaak, . Ektha. . govind. and . Anjana. Thomas. Opportunistic infection In HIV. Opportunistic infections are those that occur more frequently in immunocompromised populations and are often more clinically severe in this group of people.. PrEP. ) Use During Sexual Events by Sexual Minority Men in Canada’s Three Largest Metropolitan Areas. Nathan J. Lachowsky. 1,2,3*. , Cui Z. 3. , . Bacani. N. 3. , Sang JM. 3,4. , Lal A. 3. , Messier-Peet M. use of . antibiotic. . prophylaxis. in . surgery. . at. Bach Mai Hospital. Patrick De Mol. Projet de pharmacie . clinique. Bach Mai . Hospital. , Hanoi, . Vitenam. – 12 . November. 2015. Importance of .